Critical Path Institute is a catalyst in the development of new approaches to advance medical innovation and regulatory science.
We achieve this by leading teams that share data, knowledge, and expertise, resulting in sound, consensus-based science. More…
Upcoming Events
-
Aug 17, 2022 Register Now | Addressing the Gaps in Clinical Trial Readiness for FSHD
-
Sep 13, 2022 - Sep 14, 2022 Register Now | 2022 RDCA-DAP Workshop, September 13-14
-
Sep 22, 2022 Workshop: Accelerating Medical Product Development in Kidney Transplantation Through a Public-private Partnership
-
Oct 13, 2022 - Oct 14, 2022 Register Now: DIA 2022 Digital Technology in Clinical Trials Conference
Past Events
-
Jun 30, 2022 Sample Size Calculator for a Surrogate Endpoint in Kidney Transplant Clinical Trials
-
Jun 15, 2022 View Now | Using Ontologies to Standardize Rare Disease Data Collection presented by Monarch Initiative
Successes
- COA Qualification from FDA for Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD)
- Qualification of drug-induced kidney injury (DIKI) clinical safety biomarker, composite measure
- COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
- C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)
- C-Path’s PKDOC Secures EMA Qualification Opinion for Enrichment Biomarker in ADPKD
- C-Path’s PKDOC Secures FDA Qualification for Enrichment Biomarker in ADPKD
- Regulatory Support For Autosomal Dominant Polycystic Kidney Disease Biomarker
- C-Path Opportunities Table
- EMA Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development
- FDA and EMA issue first-of-their-kind Letters of Support for two Kidney Biomarkers
News
-
Aug 5, 2022 PRO Consortium Announces Publication of Open Access Article
-
Jul 25, 2022 Diary for Irritable Bowel Syndrome Symptoms-Constipation Now Available for Licensing
-
Jul 15, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials
-
Jul 14, 2022 C-Path’s Dr. Amanda Klein Promoted to Transplant Therapeutic Consortium Executive Director
-
Jun 30, 2022 Diamyd Medical Joins International Consortium in Type 1 Diabetes
-
Jun 29, 2022 C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research